Nowakowska Beata, Kacprzak-Bergman Irma
Laboratorium Immunologii Tkankowej Instytutu Immunologii i Terapii Doświadczalnej PAN im L. Hirszfelda we Wrocławiu.
Postepy Hig Med Dosw (Online). 2004;58:458-62.
Infection by hepatitis C virus (HCV) is a growing public-health concern. After infection, 80% of infected subjects develop chronic viremia. Some developing chronic liver disease, liver cirrhosis, and hepatocellular carcinoma several years after the initial infection. The remaining 20% are able to control the infection, clearing the virus spontaneously. It is generally accepted that genes within the major histocompatibility complex play a central role in the development of the immune response against HCV. The search has focused on HLA gene products to identify disease susceptibility genes. No significant associations were shown between HLA class I and disease or response to interferon therapy. Several studies have shown an association of class II alleles with clinical outcome after HCV infection. However, which genes are associated with one outcome or another seems to depend on the ethnicity of the infected. Only spontaneous hepatitis virus clearance has been described as being strong associated with mainly, DQB10301 or DRB11101, DRB1*1104 alleles.
丙型肝炎病毒(HCV)感染是一个日益受到关注的公共卫生问题。感染后,80%的感染者会发展为慢性病毒血症。一些人在初次感染几年后会发展为慢性肝病、肝硬化和肝细胞癌。其余20%的人能够控制感染,自发清除病毒。人们普遍认为,主要组织相容性复合体内的基因在针对HCV的免疫反应发展中起核心作用。研究重点一直放在HLA基因产物上,以确定疾病易感基因。未发现HLA I类与疾病或干扰素治疗反应之间存在显著关联。多项研究表明,II类等位基因与HCV感染后的临床结局有关。然而,哪些基因与哪种结局相关似乎取决于感染者的种族。只有自发清除肝炎病毒被描述为主要与DQB10301或DRB11101、DRB1*1104等位基因密切相关。